C
LYEL icon

Covestor’s Lyell Immunopharma LYEL Stock Holding History

Covestor’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4
Closed – – 2509
2024
Q4 		$0 Buy
4
+2
+100% +$40 ﹤0.01% 2518
2024
Q3 		$0 Hold
2
– – ﹤0.01% 2510
2024
Q2 		$0 Hold
2
– – ﹤0.01% 2527
2024
Q1 		$0 Hold
2
– – ﹤0.01% 2524
2023
Q4 		$0 Hold
2
– – ﹤0.01% 2463
2023
Q3 		$0 Hold
2
– – ﹤0.01% 2444
2023
Q2 		$0 Buy
2
+1
+100% +$55 ﹤0.01% 2431
2023
Q1 		$0 Hold
1
– – ﹤0.01% 2342
2022
Q4 		$0 Sell
1
-1
-50% -$99 ﹤0.01% 2369
2022
Q3 		$0 Hold
2
– – ﹤0.01% 2336
2022
Q2 		$0 Buy
+2
New +$204 ﹤0.01% 2168

Other funds holding LYEL

MM
MWG Management Road Town, Tortola, British Virgin Islands $81.3M AUM 2.28% 1-Year Est. Return
FCMI
Foresite Capital Management IV Larkspur, California $290M AUM 143.88% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $202M AUM 2.79% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $732M AUM 275.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $362M AUM 386.37% 1-Year Est. Return
VP
venBio Partners San Francisco, California $519M AUM 339.42% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
AI
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Covestor's LYEL Position: Q1 2025 in Review

Covestor sold out of Lyell Immunopharma (LYEL) in Q1 2025, closing a stake of 4 shares.

Covestor first reported a position in LYEL in Q2 2022 and held it in 11 quarters. The position peaked at $0 in Q4 2024. 112 funds tracked by Wall St. Rank hold LYEL as of Q1 2025.

  • Covestor reported no remaining Lyell Immunopharma position as of Q1 2025 after selling out during the quarter.
  • Covestor sold 4 Lyell Immunopharma shares in Q1 2025.
  • Covestor first reported a position in Lyell Immunopharma in Q2 2022 and held it in 11 quarters.
  • Covestor's Lyell Immunopharma position peaked at $0 in Q4 2024.
  • 112 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2025.

Based on Covestor's 13F filing for Q1 2025, filed 12 May 2025.